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Hearing loss is a clinically and genetically heterogeneous disorder and is the most common human disability (Shrivastava, Shrivastava, & Ramasamy, [2016](#mgg3917-bib-0005){ref-type="ref"}). Both environmental and genetic factors were shown in the pathogenesis of hearing loss such as iodine deficient diet, infections, ototoxic drug treatment, or gene variants (<http://hereditaryhearingloss.org/>) (Morton & Nance, [2016](#mgg3917-bib-0002){ref-type="ref"}; Shrivastava et al., [2016](#mgg3917-bib-0005){ref-type="ref"}; Wonkam et al., [2013](#mgg3917-bib-0008){ref-type="ref"}). Nonsyndromic hearing loss (NSHL) can be inherited as an autosomal recessive (AR), autosomal dominant (AD), X‐linked (dominant or recessive), or mitochondrial trait (Liu et al., [2005](#mgg3917-bib-0001){ref-type="ref"}; Snoeckx et al., [2005](#mgg3917-bib-0006){ref-type="ref"}; Wang, Han, Khan, & Zhang, [2017](#mgg3917-bib-0007){ref-type="ref"}). Identifying novel sequence variants in populations provide valuable information for public health, particularly for genetic screening of the NSHL.

In our study, we recruited a total of 40 unrelated individuals affected by NSHL from Bannu and Kohat districts in Khyber Pakhtunkhwa (KPK) province, Pakistan. A clinical questionnaire was used to collect medical history and rule out the history of other diseases potentially affecting hearing and environmental factors such as antibiotic use, excessive noise exposure, and infection that could cause hearing loss. Detailed physical examination did not reveal other abnormal findings than hearing loss. Palpable goiters and other dysmorphic features were not observed in any of the participants with hearing loss; their hearing was ranging from severely impaired to deaf, listed in Figure [1](#mgg3917-fig-0001){ref-type="fig"} and Table [1](#mgg3917-tbl-0001){ref-type="table"}. All of the probands had bilateral, prelingual hearing loss consistent with a congenital origin. There was no previous family history of hearing loss in the participants. The study design and protocol were approved by the Institutional Review Board of (IRB) Quaid‐i‐Azam University Islamabad Pakistan, the Ethical Review Committee (ERC) of Peking Union Medical College (Beijing, China), and China Medical University (Shenyang, China). Written informed consents to conduct and publish the study were obtained from all participating individuals and their parents. All 40 individuals were screened by polymerase chain reaction (PCR) and Sanger sequencing for variants in *GJB2* (gap junction protein beta 2; NM_004004.5) gene which is the most commonly mutated gene in recessive NSHL (Liu et al., [2005](#mgg3917-bib-0001){ref-type="ref"}; Snoeckx et al., [2005](#mgg3917-bib-0006){ref-type="ref"}). We found known homozygous as well as compound heterozygous variants in 15 individuals. Four homozygous patients had *GJB2*; c. 370C \> T; p.Gln124\*, six had *GJB2;* c.35delG; p.Gly12Valfs\*2, three compound heterozygotes had *GJB2;* c.\[71G \> A\];c.\[231G \> A\]; p.\[p.Trp24\*\];p.\[Trp77\*\], and two had *GJB2;* c.\[−23 + 1G\>A\]; c.\[231G \> A\]; p.\[N/A\]; p.\[Trp77\*\] variants respectively (Table [1](#mgg3917-tbl-0001){ref-type="table"}). The 25 individuals, who were negative for *GJB2* gene variants, were screened by targeted next generation sequencing (TNGS) technology using the Ion Torrent platform for a panel of 63 genes implicated in hearing loss as described previously (Wang et al., [2017](#mgg3917-bib-0007){ref-type="ref"}). We identified 20 variants in 14 genes (*SLC26A4, KCNQ4, MYO15A, TMPRSS3, ESPN, TMC1, GIPC3, LHFPL5, WFS1, DFNB59, GRXCR1, ESRRB,* and *LRTOMT*). Ten were novel such as two homozygous missense variant in *MYO15A* c.\[9518‐2A \> G\];p.\[N/A\], c.3944G \> A;p.Gly1315Glu*,* one novel variant c.199T \> G; p.Tyr67Asp in *LHFPL5* in two unrelated individuals, one novel variant c.2519G \> A; p.Trp840\* in *ESPN*, one in *KCNQ4* c.1288G \> A; p.Glu430Lys, one in *ESRRB* c521G \> A; p.Arg174His, one in *DFNB59* c.147T \> A; p.Tyr49\*, one in *GIPC3* c.759C \> G; p.Ser253Arg, one in *TMC1* c.662A \> G; p.Tyr221Cys, and one novel variant in *LRTOMT* c.154C \> T; p.Arg52Trp (Figure [1](#mgg3917-fig-0001){ref-type="fig"}, Table [1](#mgg3917-tbl-0001){ref-type="table"}). The functional effect of the variants was predicted using the in silico tools including Polyphen2 (<http://genetics.bwh.harvard.edu/pph2/>), Sorting Intolerant from Tolerant (SIFT) (<http://sift.jcvi.org/>), PROVEAN (<http://www.provean.jcvi.org>) Mutation Taster (<http://www.mutationtaster.org/>), Human Splicing Finder (HSF) (<http://www.umd.be/HSF>) and CADD (<https://cadd.gs.washington.edu>) (Table [1](#mgg3917-tbl-0001){ref-type="table"}).

![(a) Novel sequence variants identified in *ESPN, KCNQ4, ESRRB, MYO15A, LHFPL5, DFNB59, GIPC3, TMC1,* and *LRTOMT* in our cohort from Pakistan. (b) Audiometry of individuals in our cohort with hearing loss](MGG3-7-e917-g001){#mgg3917-fig-0001}
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Clinical features and genotyping in hearing loss individuals

  Subjects   Sex   Age   Gene        Transcript ID    Variant                                Allele     Effect on protein                             Mutation type             Known/Novel   Variant interpretation prediction scores   ACMG classification                            
  ---------- ----- ----- ----------- ---------------- -------------------------------------- ---------- --------------------------------------------- ------------------------- ------------- ------------------------------------------ --------------------- ------- -------- ------- ------
  1          M     7     *GJB2*      NM_004004.5      c.\[71G \> A\]; \[71G \> A\]           Hom        p.\[Trp24\*\];\[Trp24\*\]                     Nonsense                  Known         --                                         --                    --      1        36      PVS1
  2          M     7     *GJB2*      NM_004004.5      c.\[71G \> A\];\[71G \> A\]            Hom        p.\[Trp24\*\];\[Trp24\*\]                     Nonsense                  Known         --                                         --                    --      1        36      PVS1
  3          M     9     *GJB2*      NM_004004.5      c.\[71G \> A\];c.\[231G \> A\]         Comp Het   p.\[Trp24\*\];p.\[Trp77\*\]                   Nonsense                  Known         --                                         --                    --      1        36/38   PVS1
  4          F     6     *GJB2*      NM_004004.5      c.\[370C \> T\];\[370C \> T\]          Hom        p.\[Gln124\*\];\[Gln124\*\]                   Nonsense                  Known         --                                         --                            1        34      PVS1
  5          F     5     *GJB2*      NM_004004.5      c.\[370C \> T\];\[370C \> T\]          Hom        p.\[Gln124\*\];\[Gln124\*\]                   Nonsense                  Known         --                                         --                    --      1        34      PVS1
  6          M     11    *GJB2*      NM_004004.5      c.\[370C \> T\];\[370C \> T\]          Hom        p.\[Gln124\*\];\[Gln124\*\]                   Nonsense                  Known         --                                         --                    --      1        34      PVS1
  7          F     13    *GJB2*      NM_004004.5      c.\[370C \> T\];\[370C \> T\]          Hom        p.\[Gln124\*\];\[Gln124\*\]                   Nonsense                  Known         --                                         --                    --      1        34      PVS1
  8          M     9     *GJB2*      NM_004004.5      c.\[35delG\];\[35delG\]                Hom        p.\[(Gly12Valfs\*2)\];\[(Gly12Valfs\*2)\]     Frameshift                Known         --                                         --                    --      --       --      PVS1
  9          F     8     *GJB2*      NM_004004.5      c.\[35delG\];\[35delG\]                Hom        p.\[(Gly12Valfs\*2)\];\[(Gly12Valfs\*2)\]     Frameshift                Known         --                                         --                    --      --       --      PVS1
  10         F     10    *GJB2*      NM_004004.5      c.\[35delG\];\[35delG\]                Hom        p.\[(Gly12Valfs\*2)\];\[(Gly12Valfs\*2)\]     Frameshift                Known         --                                         --                    --      --       --      PVS1
  11         F     7     *GJB2*      NM_004004.5      c.\[35delG\];\[35delG\]                Hom        p.\[(Gly12Valfs\*2)\];\[(Gly12Valfs\*2)\]     Frameshift                Known         --                                         --                    --      --       --      PVS1
  12         M     5     *GJB2*      NM_004004.5      c.\[35delG\];\[35delG\]                Hom        p.\[(Gly12Valfs\*2)\];\[(Gly12Valfs\*2)\]     Frameshift                Known         --                                         --                    --      --       --      PVS1
  13         M     8     *GJB2*      NM_004004.5      c.\[35delG\];\[35delG\]                Hom        p.\[(Gly12Valfs\*2)\];\[(Gly12Valfs\*2)\]     Frameshift                Known         --                                         --                    --      15       --      PVS1
  14         M     9     *GJB2*      NM_004004.5      c.\[−23 + 1G\>A\];c.\[231G \> A\]      Comp Het   p.\[*N*/A\];p.\[Trp77\*\]                     Splice site; Frameshift   Known         --                                         --                    --      --       −/38    PVS1
  15         M     10    *GJB2*      NM_004004.5      c.\[−23 + 1G\>A\];\[−23 + 1G\>A\]      Hom        p.\[*N*/A\];\[*N*/A\]                         Splice site               Known         --                                         --                    --      --       --      PVS1
  16         M     8     *SLC26A4*   NM_000441.1      c.\[679G \> C\];\[679G \> C\]          Hom        p.\[Ala227Pro\];\[Ala227Pro\]                 Missense                  Known         1                                          −4.94                 0.001   1        30      PM2
  17         F     7     *SLC26A4*   NM_000441.1      c.\[679G \> C\];\[679G \> C\]          Hom        p.\[Ala227Pro\];\[Ala227Pro\]                 Missense                  Known         1                                          −4.94                 0.001   1        30      PM2
  18         F     7     *SLC26A4*   NM_000441.1      c.\[679G \> C\];\[679G \> C\]          Hom        p.\[Ala227Pro\];\[Ala227Pro\]                 Missense                  Known         1                                          −4.94                 0.001   1        30      PM2
  19         M     6     *SLC26A4*   NM_000441.1      c.\[716T \> A\];\[716T \> A\]          Hom        p.\[Val239Asp\];\[Val239Asp\]                 Missense                  Known         0.845                                      −5.67                 0.001   1        29.5    PP2
  20         M     7     *SLC26A4*   NM_000441.1      c.\[716T \> A\];\[716T \> A\]          Hom        p.\[Val239Asp\];\[Val239Asp\]                 Missense                  Known         0.845                                      −5.67.                0.001   1        29.5    PP2
  21         M     8     *MYO7A*     NM_000260.3      c.\[1258A \> T\];\[1258A \> T\]        Hom        p.\[Lys420\*\];\[Lys420\*\]                   Nonsense                  Known         --                                         --                    --      1        41      PVS1
  22         M     9     *MYO7A*     NM_000260.3      c.\[1258A \> T\];\[1258A \> T\]        Hom        p.\[Lys420\*\];\[Lys420\*\]                   Nonsense                  Known         --                                         --                    --      1        41      PVS1
  23         F     14    *MYO7A*     NM_000260.3      c.\[4838delA\];\[4838delA\]            Hom        p.\[Asp1613Valfs\*32\];\[Asp1613Valfs\*32\]   Frameshift                Known         --                                         --                    --      --       --      PVS1
  24         M     13    *MYO15A*    NM_016239.3      c.\[9518−2A \> G\]; \[9518−2A \> G\]   Hom        p.\[*N*/A\];\[*N*/A\]                         Splice site               Novel         --                                         --                    --      1        19      PVS1
  25         F     15    *MYO15A*    NM_016239.3      c.\[3944G \> A\]; \[3944G \> A\]       Hom        p.\[Gly1315Glu\]; \[Gly1315Glu\]              Missense                  Known         1                                          −7.7                  0.0     1        24.6    PM2
  26         M     7     *GRXCR1*    NM_001080479.2   c.\[784C \> T\];\[784C \> T\]          Hom        p.\[Arg262\*\];\[Arg262\*\];                  Nonsense                  Known         --                                         --                    --      1        50      PVS1
  27         M     12    *GRXCR1*    NM_001080479.2   c.\[784C \> T\];\[784C \> T\]          Hom        p.\[Arg262\*\];\[Arg262\*\];                  Nonsense                  Known         --                                         --                    --      1        50      PVS1
  28         M     10    *LHFPL5*    NM_182548.3      c.\[199T \> G\];\[199T \> G\]          Hom        p.\[Tyr67Asp\];\[Tyr67Asp\]                   Missense                  Novel         1                                          −6.12                 0.032   1        27.8    PM2
  29         M     8     *LHFPL5*    NM_182548.3      c.\[199T \> G\];\[199T \> G\]          Hom        p.\[Tyr67Asp\];\[Tyr67Asp\]                   Missense                  Novel         1                                          −6.12                 0.032   1        27.8    PM2
  30         M     7     *TMPRSS3*   NM_024022.2      c.\[727G \> A\];\[727G \> A\]          Hom        p.\[Gly243Arg\];\[Gly243Arg\]                 Missense                  Known         1                                          −7.53                 0.01    1        35      PM2
  31         F     9     *TMPRSS3*   NM_024022.2      c.\[1219T \> C\];\[1219T \> C\]        Hom        p.\[Cys407Arg\];\[Cys407Arg\]                 Missense                  Known         0.997                                      −3.98                 0.122   1        23.3    PM2
  32         M     6     *WFS1*      NM_006005.3      c.\[2338G \> A\];\[1219T \> C\]        Hom        p.\[Gly780Ser\];\[Gly780Ser\]                 Missense                  Known         0.896                                      −1.34                 0.060   1        23.7    PM2
  33         M     16    *WFS1*      NM_006005.3      c.\[2590G \> A\];\[2590G \> A\]        Hom        p.\[Glu864Lys\];\[Glu864Lys\]                 Missense                  Known         1                                          −1.68                 0.045   1        28.6    PM2
  34         M     22    *ESPN*      NM_031475.2      c.\[2519G \> A\];\[2519G \> A\]        Hom        p.\[Trp840\*\];\[Trp840\*\]                   Nonsense                  Known         --                                         --                    --      1        42      PVS1
  35         M     13    *KCNQ4*     NM_004700.3      c.\[1288G \> A\];\[1288G \> A\]        Hom        p.\[Glu430Lys\];\[Glu430Lys\]                 Missense                  Novel         0.956                                      −0.72                 0.376   1        18.19   PP2
  36         M     16    *ESRRB*     NM_004452.3      c.\[521G \> A\];\[521G \> A\]          Hom        p.\[Arg174His\];\[Arg174His\]                 Missense                  Novel         0.860                                      −4.27                 0.046   1        27.5    PM2
  37         M     10    *DFNB59*    NM_001042702.4   c.\[147T \> A\];\[521G \> A\]          Hom        p.\[Tyr49\*\];\[Tyr49\*\]                     Nonsense                  Novel         --                                         --                    --      1        35      PVS1
  38         M     8     *GIPC3*     NM_133261.2      c.\[759C \> G\];\[759C \> G\]          Hom        p.\[Ser253Arg\];\[Ser253Arg\]                 Missense                  Novel         0.995                                      −3.87                 0.043   0.9994   23.2    PM2
  39         F     9     *TMC1*      NM_138691.2      c.\[662A \> G\];\[662A \> G\]          Hom        p.\[Tyr221Cys\];\[Tyr221Cys\]                 Missense                  Novel         1                                          −6.34                 0.045   1        27.3    PM2
  40         F     11    *LRTOMT*    NM_001145308.4   c.\[154C \> T\];\[154C \> T\]          Hom        p.\[Arg52Trp\];\[Arg52Trp\]                   Missense                  Known         0.988                                      −1.79                 0.001   1        26.5    PVS1

Abbreviations: Comp. Het, Compound Heterozygous; F, Female; Hom, Homozygous; M, Male.
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Furthermore, these novel variants was neither present in the dbSNP (<http://www.ncbi.nlm.nih.gov/SNP/),Exome> Variant Server (<http://evs.gs.washington.edu/EVS/>), GnomAD (<https://gnomad.broadinstitute.org>), Human gene mutation database (HGMD, <http://www.hgmd.cf.ac.uk/ac/index.php>), 1,000 Genomes (<http://www.1000genomes.org/>), and Exome aggregation consortium (ExAC) (<http://www.exac.broadinstitute.org>). Finally, for the interpretation of variants, the American College of Medical Genetics and Genomics (ACMG) 2015 guidelines were used (Table [1](#mgg3917-tbl-0001){ref-type="table"}) (Richards et al., [2015](#mgg3917-bib-0003){ref-type="ref"}).

None of the novel variants were present in 200 ethnically matched control individuals confirmed by PCR and Sanger sequencing. The \'15 of 40 patients had known variants in *GJB2* (described above), 5  of 40 patients had known variants in *SLC26A4* c.679G \> C; p.Ala227Pro*,* 3 of 40 had known variants in *MYO7A* c.1258A \> T; p.Lys420\*, c.4838delA; p.Asp1613Valfs\*32, 2 of 40 had known variants in *GRXCR1* c.784C \> T; p.Arg262\**,* 2 of 40 had known variants in *TMPRSS3* c.727G \> A; p.Gly243Arg, c.1219T \> C; p.Cys407Arg, 2 of 40 had known variants in *WFS1* c.2338G \> A; p.Gly780Ser, c.2590G \> A; p.Glu864Lys*,* 1 of 40 had known variant in *ESPN* c.2519G \> A; p.Trp840\**,*1  of 40 had known variant in *LRTMOT* c.154C \> T; p.Arg52Trp and were already known to be associated with syndromic or NSHL (Salman et al., [2015](#mgg3917-bib-0004){ref-type="ref"}; Wang et al., [2017](#mgg3917-bib-0007){ref-type="ref"}). The *GJB2* variants were the most common variants in our patient cohort. Our study showed that *GJB2* is the most common gene found mutated in our Pakistani cohort which is similar to other cohorts around the world (Salman et al., [2015](#mgg3917-bib-0004){ref-type="ref"}; Snoeckx et al., [2005](#mgg3917-bib-0006){ref-type="ref"}; Wang et al., [2017](#mgg3917-bib-0007){ref-type="ref"}). We found the *GJB2* variants c.35delG; p.Gly12Valfs\*2, c.71G \> A; p.Trp24\* and c. \[71G \> A\]; c. \[231G \> A\]; p. \[p.Trp24\*\]; p. \[Trp77\*\] as the most common, 15 of 40 patients in our cohort however their frequency is variable worldwide (Salman et al., [2015](#mgg3917-bib-0004){ref-type="ref"}).

In our patient cohort we found 15/40 patients had *GJB2* variants, (5/40) had *SLC26A4,* and (3/40) had *MYO7A* variants responsible for NSHL. We found the incidence of *GJB2* variants is higher compared to other populations. While this would argue for screening for *GJB2* variants in the first place, we found a comparably high incidence for *SLC26A4* and *MYO7A* variants together. Future research could specifically take advantage of using TNGS in the Pakistani cohort to capture a larger proportion of NSHL cases of genetic origin. We expect our study will enhance public awareness toward this hearing loss trouble and genetic counseling significance for the affected families and their members. This study expanded a spectrum of disease causing variants in genes involved in causing hearing loss.
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The URLs for data presented herein are as follows:

1,000 Genomes: <http://www.1000genomes.org/>

Exome Variant Server: <http://evs.gs.washington.edu/EVS/>

ExAC: <http://exac.broadinstitue.org/>

dbSNP: <http://www.ncbi.nlm.nih.gov/SNP/>

OMIM: <http://www.omim.org/>

HGMD: <http://www.biobase-international.com/products/hgmd>

SIFT: <http://sift.jcvi.org/>

Polyphen2: <http://genetics.bwh.harvard.edu/pph2/>

IGV: <http://www.broadinstitute.org/igv/>

ANNOVAR: <http://annovar.openbioinformatics.org/en/latest/>

Mutation Taster: <http://www.mutationtaster.org/>

OMIM: <http://www.omim.org/>

UCSC Genome Browser: <http://genome.ucsc.edu>
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